Orca Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
1,807
-12
-0.7% -$12.3K 1.57% 21
2026
Q1
$1.67M Sell
1,819
-68
-4% -$68.9K 1.42% 24
2025
Q4
$2.03M Buy
1,887
+11
+0.6% +$10.5K 1.6% 20
2025
Q3
$1.43M Buy
1,876
+19
+1% +$14.1K 1.17% 28
2025
Q2
$1.45M Buy
+1,857
New +$1.44M 1.31% 27

Other funds holding LLY

Orca Investment Management's LLY Position: Q2 2026 in Review

Orca Investment Management reduced its Eli Lilly (LLY) stake by 0.66% in Q2 2026, selling an estimated $12.3K and leaving 1,807 shares worth $2.17M. The position accounts for 1.57% of the portfolio, ranked #21.

Orca Investment Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Orca Investment Management held 1,807 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • Orca Investment Management sold 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 1.57% of Orca Investment Management's portfolio in Q2 2026, its #21 holding.
  • Orca Investment Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Orca Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.